Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Bonus Story from MarketBeat Media
Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?Reported by Peter Frank. Article Posted: 6/18/2026. 
Key Points
- Trupanion beat Q1 expectations and posted record first-quarter subscription margins, but the stock has continued to struggle.
- Subscriber retention remains a strength, helping support the company’s monthly pet insurance model despite competitive pressure.
- The bull case depends on Trupanion proving that revenue growth and customer loyalty can translate into durable profitability.
- Special Report: Forget SpaceX. Buy the company Musk can't replace.
Trupanion (NASDAQ: TRUP) has spent years telling investors a compelling story about pet insurance. Yet despite steadily rising revenue, the company has struggled to turn that growth into profits. Now, with first-quarter results building on the positive momentum from 2025, Trupanion is delivering record margins, an earnings beat, and strong subscriber retention.
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge.
Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks.
Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
Still, investors appear cautious. Growth may not be the issue facing the company. Compared with other countries, the United States remains far behind in pet insurance adoption. Instead, rising veterinary costs and industry competition may be the reasons investors remain unconvinced and may need more patience. Trupanion Delivers Stronger Financial ResultsTrupanion is not typically top of mind when investors discuss insurers. It does not pay a dividend, and subscription insurance for cats and dogs is a niche that rarely attracts much attention. The company is also unusual in the insurance world because its policies are monthly rather than annual contracts that customers renew each year. The company’s first-quarter results showed, however, that its model is working. For the first three months of the year, Trupanion reported revenue of $384 million, up 12% from a year earlier and above expectations. Net income improved from a $1.5 million loss a year ago to a profit of $4.9 million, or 11 cents per share, more than 50% above analysts’ estimates. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 42% to $17.4 million. While the earnings beat was notable, operating margins told a more compelling story. Trupanion’s subscription adjusted operating margin rose to 14.2%, a first-quarter record, up from 12.9% a year earlier. Adjusted operating income also increased 29% year-over-year to more than $40 million. Subscriber Loyalty Remains a StrengthTrupanion’s business extends beyond its direct cat-and-dog insurance operations in the United States. The company also operates the lower-cost Furkin and PHI Direct brands in Canada, employer programs, and pet health products. Its VetDirect Pay system integrates insurance coverage into veterinary claims systems. Over the past few years, the company has also expanded through acquisitions into several European countries, though that remains a small part of the business with only about 64,000 pets covered. For a company built on monthly subscriptions, that metric is critical, and it also tells a generally positive story. Overall, subscription revenue for the quarter rose 16% to $269.5 million, driven by a 5% increase in enrolled subscription pets to 1.1 million. Including all business lines, total pets enrolled declined 2% year-over-year. Even so, monthly average revenue per pet increased to $85.79 from $77.53 a year earlier. This growth is being supported by what appears to be strong subscriber loyalty. As of March 31, Trupanion reported monthly retention of 98.35%, meaning fewer than two out of every 100 subscribers cancelled. In all, the company announced in May that it had reached more than $4 billion in total veterinary invoices paid on behalf of policyholders. Competition and Rising Costs Still MatterGiven the nature of the business, investors cannot assume a smooth path from here. With its monthly subscription model, the company faces potential churn and pricing pressure. Competition is also increasing in the financial services sector. Traditional insurers, direct-to-consumer startups, and employer-benefit pet insurance programs have all entered or expanded in the category. Nationwide, Lemonade (NYSE: LMND), MetLife (NYSE: MET), and the Healthy Paws unit of Chubb (NYSE: CB) are among the companies in the segment. On the positive side, Trupanion’s distribution model relies heavily on recommendations from veterinarians, which provides some protection. But maintaining that advantage requires continued investment in veterinary relationships and brand presence. The cost of acquiring new subscribers is also rising, increasing to $315 in the quarter from $267. Meanwhile, veterinary costs have climbed sharply over the past decade, driven by advances in veterinary medicine that now include MRI imaging, cancer treatments, orthopedic surgeries, and other procedures that can cost thousands of dollars. Wall Street Remains Cautiously OptimisticAnalyst opinion, as well as the company’s stock price, reflects these tensions. Despite the improved results, shares in the company have fallen by over 35% since the start of the year. Over the past year, the stock is down more than 50%. And while two analysts have assigned a Buy rating to the stock, three recommend Hold, and one suggests Sell, indicating just how tentative the outlook remains. Overall, the company carries a Hold rating. Even with that Hold rating, the company’s lowest 12-month target price is $31, still well above current trading levels. The average target is $42.25, more than 75% higher. Growth Potential May Reward PatienceFor investors considering Trupanion, patience may be the key. Pet insurance remains dramatically underpenetrated in North America, so there is room to grow. In the United Kingdom and Sweden, for example, pet insurance ownership rates run well into the double digits. In the United States and Canada, the figure is in the low single digits. The first-quarter results also deserve attention. A record operating margin and a strong earnings beat should not be ignored, along with continued evidence that the subscription model generates the kind of customer loyalty that supports long-term economics. For retail investors who are comfortable owning a company that is still proving its profitability story, TRUP deserves a place on the research list. That said, this is not a stock for investors who need certainty or income. The company is still working to prove its profitability. The next one or two quarterly reports are likely to provide more clarity. The first quarter of 2026 was certainly encouraging, but in Trupanion’s case, the full story is still being written. |
